hero image

Our Programs

Education & Programming

National CMV's programs deliver education about congenital CMV to women of childbearing age through strategic partnerships, public health initiatives, and grassroots advocacy efforts, and we fund research regarding CMV prevention, treatment, and intervention. Learn more about our impact below.
 

Early Career Congenital CMV Research Award

The National CMV Foundation is pleased to announce a $10,000 award to fund innovative research related to maternal or congenital cytomegalovirus (CMV) infections. This award is made possible by individual, charitable contributions to the National CMV Foundation in support of research that will lead to the elimination of disabilities due to congenital CMV infection.

The goal of this award is to encourage early career researchers to pursue research on maternal or congenital CMV infections. The award can fund or be applied to projects in areas including public health, epidemiology, diagnosis, treatment, outcomes, basic science, or vaccine development.

Eligibility:
Early career researchers including mentored pre- and post-doctoral trainees or junior faculty members who have not been a principal investigator (PI) on a National Institutes of Health (NIH) grant may apply for the award. Trainee applicants must provide a letter of support and a mentoring plan from the Mentor. Applications will be accepted from researchers in the United States and Canada. 

Grant Title: Early Career Congenital CMV Research Award
Selection Method: Competitive Bid
Mini-Grant Period: December 5, 2018 to December 5, 2019
Funding Cycle: 1 Year
Mini-Grant Extension: This grant has no annual renewal; grantees must reapply yearly.
Award Amount: $10,000
Number of Awards: Up to 2
Issuing Agency: National CMV Foundation, PO BOX 18322, Tampa, FL 33679

The Request for Application (RFA), Application Form and Biographical Sketch Form are available for download at the links below. 

Award Announcement RFA
Facepage Form
Biographical Sketch Form

The 2018 application period is now closed and submissions are under review. Thank you for your interest!

Learn more about our 2017 recipient and his proposed research!


Pediatric Infectious Disease Society (PIDS) CMV Fellowship Award for CMV Research

The PIDS Fellowship Award for CMV Research, supported by the National CMV Foundation, will specifically fund research related to congenital cytomegalovirus (CMV). This award is a two-year award ($22,500 per year) for trainees with an MD, PhD, or MD-PhD degree. All applicants must have a mentor (primary or co-supervisor) who is an active PIDS member. 

The application period for this fellowship award has closed. Learn more about our 2017 recipient and her proposed research!


Public Health Awareness Mini Grant

In its inaugural year, National CMV received a high volume of extremely interesting proposals for projects that will increase cCMV awareness in the United States. We will be funding 3 proposals for the July 30, 2018 to July 30, 2019 year at an amount not to exceed $7,500 each. Grant activities during the year period are classified as either one-time events or ongoing projects. Applications were submitted by both United States-based private or public-sector organizations, including non-profit and for-profit organizations or any unit of local, state, or federal government. 

Grant Title:  Raising Awareness of Congenital CMV
Selection Method: Competitive Bid
Mini-grant Period: July 30, 2018 to July 30, 2019
Mini-grant Extension: This grant has no annual renewal; grantees must reapply yearly.
Award Amount: Up to $7,500
Funding Cycle: 1 Year
Number of Awards: Up to 3
Issuing Agency: National CMV Foundation, PO Box 18322 Tampa, Florida 33679

Award Annoucement RFA

The 2018 application period is now closed and information regarding the awards will be announced late summer. Stay tuned for updates!
 

The doctors knew Cameron's problem was viral, but they couldn't pinpoint the virus. Finally, after about 2 days, my placenta lab test came back and it was infected with CMV. I was so relieved that Cameron was going to survive, but I was not ready for the next bombshell. The NICU doctor told us that as a result of is brain damage, Cameron would not be able to “walk, talk or learn."
— Julie, Mother